RILIMOGENE GLAFOLIVEC
UNII 7PLH7RM47T

Substance Identification & Data

This profile provides standardized clinical and technical data for Rilimogene Glafolivec, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 7PLH7RM47T.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1225283-42-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

7PLH7RM47T

CAS Registry Number

1225283-42-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

RILIMOGENE GLAFOLIVEC

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C29560

National Cancer Institute reference terminology for clinical and research data.

INN ID

9632

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

YY-130

Identifier assigned by the United States Adopted Names Council.

Substance Type

structurallyDiverse

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Rilimogene Glafolivec. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

RILIMOGENE GLAFOLIVEC

Common Names & Synonyms

RECOMBINANT NON-REPLICATING FOWLPOX VIRAL VECTOR EXPRESSING A MODIFIED PROSTATE SPECIFIC ANTIGEN (PSA) PLUS THREE CO-STIMULATORY MOLECULES, LYMPHOCYTE ASSOCIATED FUNCTION ANTIGEN-3 (LFA-3), INTRACELLULAR ADHESION MOLECULE-1 (ICAM-1) AND B7.1

RILIMOGENE GLAFOLIVEC [INN]

RILIMOGENE GLAFOLIVEC [USAN]

RILIMOGENE GLAFOLIVEC [WHO-DD]